HEALTHCARE

March 12, 2020

Patient Safety Movement Foundation (PSMF) – a global non-profit dedicated to unifying those involved in the healthcare ecosystem, identifying challenges that are causing patient deaths, and creating actionable solutions to mitigate them – is pleased to announce the appointment of its new chairman of the board of directors – Michael A.E. Ramsay, MD, FRCA. It also reaffirms its commitment to patient health and safety with updates to its mission, vision and values; and reestablishes its goal of achieving ZERO preventable patient deaths by 2030. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200310005733/en/ As one of PSMF’s longest-standing board members, serving since 2013, Dr. Ramsay has been an advocate for patient safety in the anesthesia world since the 1980’s...... Continue Reading

March 12, 2020

KUWAIT: Kuwait Municipality Director Ahmed Al-Manfouhi strongly instructed various municipality officials to make sure Ministry of Health’s (MoH) coronavirus-related precautionary measures are followed in various barbershops, salons, spas, sports and social clubs and cafes. “We are more concerned now with people’s safety rather than law enforcement,” Manfouhi stressed, noting that"... Continue Reading

March 12, 2020

Regulatory News:

Vifor Pharma Group recorded strong financial and operational performance in 2019 by focusing on its three strategic growth drivers while continuing to invest in its pipeline. The company exceeded its raised guidance for full-year 2019 on both net sales and EBITDA.

FINANCIAL"... Continue Reading

March 11, 2020

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the results from the TOURMALINE-MM2 study designed to evaluate the addition of NINLARO™ (ixazomib) to lenalidomide and dexamethasone in newly diagnosed transplant ineligible multiple myeloma patients. The addition of ixazomib to lenalidomide and dexamethasone resulted in an improvement in median progression-free survival (PFS) of 13.5 months (35.3 months versus 21.8 months; hazard ratio [HR] 0.83; p=0.073); however, it did not meet the threshold for statistical significance. The safety profile associated with NINLARO from the TOURMALINE-MM2 trial was generally consistent with the existing prescribing information....... Continue Reading

March 11, 2020

Global Health & Pharma (GHP), a global information sharing platform & a multi-disciplinary members community announced winners of the 2019 Technology Awards this month and recognised Sinterex as Best 3D-Printed Healthcare Products Manufacturer – Middle East.

In its announcement, GHP said, “Technology is a great"... Continue Reading

March 10, 2020

Kuwaiti Minister of Health Sheikh Dr. Basil Al-Sabah announced the recovery of the second coronavirus case of a woman, who travelled from Iran. In a statement to KUNA on Monday, the minister said that the tests showed that the woman had recovered from the symptoms of the virus.

He"... Continue Reading

March 9, 2020

Minister of Health Sheikh Dr. Basel Al-Sabah and Minister of Social Affairs and Minister of State for Economic Affairs Mariam Al-Aqeel visited Al-Joun center quarantine to check on the wellbeing of citizens and services provided there. The two ministers closely observed the medical and security systems in the center, as well as means of preventing the spread of the coronavirus, the Ministry of Social Affairs"... Continue Reading

March 9, 2020

Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today will share with members of the United States Congress that it is initiating the development of an anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-IG) to treat high-risk individuals with COVID-19, while also studying whether Takeda’s currently marketed and pipeline products may be effective treatments for infected patients. SARS-CoV-2 is the virus that causes COVID-19. Hyperimmune globulins are plasma derived-therapies that have previously been shown to be effective in the treatment of severe acute viral respiratory infections and may be a treatment option for COVID-19. As a leader in plasma-derived therapies with more than 75 years of experience in the development of plasma-derived products, Takeda has the expertise to research, develop, and manufacture a potential...... Continue Reading

March 8, 2020

WASHINGTON: US employers maintained a robust pace of hiring in February, giving the economy a strong boost heading into the coronavirus outbreak, which has stoked fears of a recession and prompted an emergency interest rate cut from the Federal Reserve.
The Labour Department’s closely watched monthly employment report on Friday also showed solid wage growth and the unemployment rate falling back"... Continue Reading

March 8, 2020

KUWAIT: Subhan polyclinic recently called for backup to help control crowds of recent expats returnees wishing to undergo precautionary medical tests, the Health Ministry said yesterday. This came in response to inquiries that many expats made after being told when they returned to Kuwait from abroad that they had to undergo tests to confirm they are free from the novel coronavirus (COVID-19) infection.